His stock holdings included Aetna Inc., Pfizer Inc, Amgen Inc., Bristol-Myers Squibb Co. and Eli Lilly & Co. On Thursday, Price listed McKesson Corp as one of the 43 stocks he intends to sell as part of a major divestiture of his financial holdings and business interests.